T
TYP
TRYPTAMINE LTD
0.04
0.00+2.70%Closed16:10 01/22 AEDT
OPEN/PREV CLOSE0.037/0.037
TODAY RANGE0.037-0.038
VOL420.98K
MARKET CAP48.50M
52 WEEK RANGE0.0080-0.057
AVG VOL (3M)4.79M
% TURNOVER0.03%
TURNOVER15.85K
P/E (TTM)-2.3457
% RANGE2.70%
EPS(TTM)-0.0162
P/E(FORWARD)-0.9500
P/B6.13
BVPS0.0062
DIVIDEND--
P/S4.872
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP34.55M
SHARES OUTSTANDING1.28B
NEXT EARNINGS02/24-03/02
FREE FLOAT909.30M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/14 21:22
Biotech Showcase 2025 Presentation
ASX·01/06 03:15
Change of Auditor
ASX·12/17/2024 22:30
Positive interim results in Phase 2a TRP-8802 IBS trial
ASX·12/03/2024 22:37
Change of Director's Interest Notice - JC
ASX·12/03/2024 22:35
Change of Director's Interest Notice - CN
ASX·12/03/2024 22:35
Change of Director's Interest Notice - GJ
ASX·12/03/2024 22:35
Change of Director's Interest Notice - MD
ASX·12/02/2024 05:24
Notification regarding unquoted securities - TYP
ASX·11/28/2024 22:28
Completion of Phase 1b study of TRP-8803 in obese subjects
ASX·11/21/2024 21:45
First patient dosed in Phase 1b study into obese subjects
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others